{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T20:32:50Z","timestamp":1777235570388,"version":"3.51.4"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100002590","name":"American Lung Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002590","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Lang Family COPD Research Fund"},{"DOI":"10.13039\/100002590","name":"American Lung Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002590","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Lang Family COPD Research Fund"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Meta-analyses have suggested the risk of cardiovascular disease (CVD) events is significantly higher after a chronic obstructive pulmonary disease (COPD) exacerbation. However, many of these studies have included a broad array of CVD events or have been limited to highly selected patient populations potentially not generalizable to the broader population of COPD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives and Methods<\/jats:title>\n                    <jats:p>We assessed the risk of atherosclerotic cardiovascular disease (ASCVD) hospitalizations after COPD hospitalization compared with before COPD hospitalization and identified patient factors associated with ASCVD hospitalizations after COPD hospitalization. This retrospective cohort study used claims data from 920,550 Medicare beneficiaries hospitalized for COPD from 2016 to 2019 in the United States. The primary outcome was risk of an ASCVD hospitalization composite outcome (myocardial infarction, percutaneous coronary intervention, coronary artery bypass graft surgery, stroke, or transient ischemic attack) in the 30 days and 1 year after COPD hospitalization relative to the same time period before COPD hospitalization. Time in the before and after COPD hospitalization time periods to a composite ASCVD hospitalization outcome were modeled using an extension of the Cox proportional hazards model, the Anderson-Gill model, with adjustment for patient characteristics. Additional analyses evaluated for interactions in subgroups associated with the composite ASCVD hospitalization outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 920,550 patients in the 30-day and 1-year cohorts (mean age, 73\u201374 yr) the hazard ratio estimate (95% confidence interval) for the composite ASCVD hospitalization outcome after COPD hospitalization versus before COPD hospitalization for the 30-day cohort was 0.99 (0.93, 1.05; P\u2009=\u20090.67), and for the 1-year cohort, it was 0.99 (0.97, 1.02; P\u2009=\u20090.53) after adjustment. We observed three subgroups that were significantly associated with higher risk for ASCVD hospitalizations 1 year after COPD hospitalization: 76+ years old, women, and COPD hospitalization severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among Medicare beneficiaries hospitalized for COPD, the risk of ASCVD hospitalization was not significantly increased 30 days or 1 year after COPD hospitalization relative to before COPD hospitalization. In subgroup analyses, we identified age 76+ years old, female sex, and COPD hospitalization severity as high-risk subgroups with increased risk of ASCVD events 1 year after COPD hospitalization. Further research is needed to characterize the COPD exacerbation populations at highest ASCVD hospitalization risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.202401-017oc","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T15:15:26Z","timestamp":1721229326000},"page":"1516-1523","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":5,"title":["Risk of Atherosclerotic Cardiovascular Disease Hospitalizations after Chronic Obstructive Pulmonary Disease Hospitalization among Older Adults"],"prefix":"10.1093","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8463-1947","authenticated-orcid":false,"given":"Christopher L.","family":"Mosher","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine"},{"name":"Duke Clinical Research Institute, Durham, North Carolina; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oyomoare L.","family":"Osazuwa-Peters","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Nanna","sequence":"additional","affiliation":[{"name":"Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil R.","family":"MacIntyre","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9188-9244","authenticated-orcid":false,"given":"Loretta G.","family":"Que","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Schuyler","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, and"},{"name":"Division of Cardiovascular Disease, Duke University School of Medicine, Durham, North Carolina"},{"name":"Duke Clinical Research Institute, Durham, North Carolina; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott M.","family":"Palmer","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine"},{"name":"Department of Population Health Sciences, and"},{"name":"Duke Clinical Research Institute, Durham, North Carolina; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily C.","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, and"},{"name":"Duke Clinical Research Institute, Durham, North Carolina; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,11,1]]},"reference":[{"key":"2026012203190594700_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.15585\/mmwr.mm6707a1","article-title":"Urban-rural county and state differences in chronic obstructive pulmonary disease\u2014United States, 2015","volume":"67","author":"Croft","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026012203190594700_bib2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1378\/chest.14-2146","article-title":"Hospital discharges, readmissions, and ED visits for COPD or bronchiectasis among US adults: findings from the nationwide inpatient sample 2001-2012 and Nationwide Emergency Department Sample 2006-2011","volume":"147","author":"Ford","year":"2015","journal-title":"Chest"},{"key":"2026012203190594700_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.rmed.2019.07.021","article-title":"Prognosis of COPD depends on severity of exacerbation history: a population-based analysis","volume":"155","author":"\u00c7olak","year":"2019","journal-title":"Respir Med"},{"key":"2026012203190594700_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00408-011-9301-8","article-title":"Risk of nonlower respiratory serious adverse events following COPD exacerbations in the 4-year UPLIFT trial","volume":"189","author":"Halpin","year":"2011","journal-title":"Lung"},{"key":"2026012203190594700_bib5","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/resp.13620","article-title":"Increased risk of major adverse cardiac events following the onset of acute exacerbations of COPD","volume":"24","author":"Reilev","year":"2019","journal-title":"Respirology"},{"key":"2026012203190594700_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1164\/rccm.201711-2239OC","article-title":"Exacerbations of chronic obstructive pulmonary disease and cardiac events. A post hoc cohort analysis from the SUMMIT randomized clinical trial","volume":"198","author":"Kunisaki","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203190594700_bib7","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1164\/rccm.202307-1122OC","article-title":"Temporal risk of nonfatal cardiovascular events after chronic obstructive pulmonary disease exacerbation: a population-based study","volume":"209","author":"Graul","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203190594700_bib8","doi-asserted-by":"crossref","first-page":"17534666221113647","DOI":"10.1177\/17534666221113647","article-title":"Association of COPD exacerbations and acute cardiovascular events: a systematic review and meta-analysis","volume":"16","author":"M\u00fcllerov\u00e1","year":"2022","journal-title":"Ther Adv Respir Dis"},{"key":"2026012203190594700_bib9","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1164\/rccm.202301-0106PP","article-title":"Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary","volume":"207","author":"Agust\u00ed","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203190594700_bib10","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1164\/rccm.202304-0691LE","article-title":"Cardiovascular Disease and Chronic Obstructive Pulmonary Disease: Adding a Third Dimension to the ABE Global Initiative for Chronic Obstructive Lung Disease 2023 Chronic Obstructive Pulmonary Disease Classification","volume":"208","author":"Kostikas","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203190594700_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00392-023-02217-0","article-title":"GOLD COPD document 2023: a brief update for practicing cardiologists","volume":"113","author":"Agusti","year":"2024","journal-title":"Clin Res Cardiol"},{"key":"2026012203190594700_bib12","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1513\/AnnalsATS.201710-815OC","article-title":"Myocardial infarction and ischemic stroke after exacerbations of chronic obstructive pulmonary disease","volume":"15","author":"Rothnie","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203190594700_bib13","doi-asserted-by":"crossref","first-page":"e024350","DOI":"10.1161\/JAHA.121.024350","article-title":"Time-dependent risk of cardiovascular events following an exacerbation in patients with chronic obstructive pulmonary disease: post hoc analysis from the IMPACT trial","volume":"11","author":"Dransfield","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2026012203190594700_bib14","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1513\/AnnalsATS.202204-317ED","article-title":"Mind the gap: addressing cardiovascular disease in chronic obstructive pulmonary disease","volume":"19","author":"Wells","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203190594700_bib15","doi-asserted-by":"crossref","first-page":"h411","DOI":"10.1136\/bmj.h411","article-title":"Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia: retrospective cohort study","volume":"350","author":"Dharmarajan","year":"2015","journal-title":"BMJ"},{"key":"2026012203190594700_bib16","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1161\/STROKEAHA.114.007429","article-title":"Hospitalization within the first year after stroke: the Dijon stroke registry","volume":"46","author":"Lainay","year":"2015","journal-title":"Stroke"},{"key":"2026012203190594700_bib17","article-title":"Risk of atherosclerotic cardiovascular disease hospitalizations after COPD hospitalization among older adults [preprint]","author":"Mosher","year":"2023"},{"key":"2026012203190594700_bib18","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1001\/jama.2020.4437","article-title":"Association between initiation of pulmonary rehabilitation after hospitalization for COPD and 1-year survival among Medicare beneficiaries","volume":"323","author":"Lindenauer","year":"2020","journal-title":"JAMA"},{"key":"2026012203190594700_bib19","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1164\/rccm.202012-4389OC","article-title":"Association between initiation of pulmonary rehabilitation and rehospitalizations in patients hospitalized with chronic obstructive pulmonary disease","volume":"204","author":"Stefan","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203190594700_bib20","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/sj.bjc.6602102","article-title":"A note on competing risks in survival data analysis","volume":"91","author":"Satagopan","year":"2004","journal-title":"Br J Cancer"},{"key":"2026012203190594700_bib21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3414\/ME0478","article-title":"Modeling repeated time-to-event health conditions with discontinuous risk intervals. An example of a longitudinal study of functional disability among older persons","volume":"47","author":"Guo","year":"2008","journal-title":"Methods Inf Med"},{"key":"2026012203190594700_bib22","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"2026012203190594700_bib23","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/01.mlr.0000160417.39497.a9","article-title":"Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors","volume":"43","author":"Birman-Deych","year":"2005","journal-title":"Med Care"},{"key":"2026012203190594700_bib24","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/MLR.0000000000000729","article-title":"Development of a claims-based frailty indicator anchored to a well-established frailty phenotype","volume":"55","author":"Segal","year":"2017","journal-title":"Med Care"},{"key":"2026012203190594700_bib25","doi-asserted-by":"crossref","first-page":"100183","DOI":"10.1016\/j.lanepe.2021.100183","article-title":"Association of entirely claims-based frailty indices with long-term outcomes in patients with acute myocardial infarction, heart failure, or pneumonia: a nationwide cohort study in Turkey","volume":"10","author":"Kundi","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"2026012203190594700_bib26","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1378\/chest.09-2029","article-title":"Increased risk of myocardial infarction and stroke following exacerbation of COPD","volume":"137","author":"Donaldson","year":"2010","journal-title":"Chest"},{"key":"2026012203190594700_bib27","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/heartjnl-2023-323487","article-title":"Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease","volume":"110","author":"Hawkins","year":"2024","journal-title":"Heart"},{"key":"2026012203190594700_bib28","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.chest.2020.02.046","article-title":"Mortality of cardiovascular events in patients with COPD and preceding hospitalization for acute exacerbation","volume":"158","author":"Wang","year":"2020","journal-title":"Chest"},{"key":"2026012203190594700_bib29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2147\/COPD.S396790","article-title":"Exacerbations predict severe cardiovascular events in patients with COPD and stable cardiovascular disease\u2014a nationwide, population-based cohort study","volume":"18","author":"L\u00f8kke","year":"2023","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026012203190594700_bib30","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s11606-018-4518-3","article-title":"Incidence of acute cardiovascular event after acute exacerbation of COPD","volume":"33","author":"Goto","year":"2018","journal-title":"J Gen Intern Med"},{"key":"2026012203190594700_bib31","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1016\/S0140-6736(21)00684-X","article-title":"The Lancet Women and Cardiovascular Disease Commission: reducing the global burden by 2030","volume":"397","author":"Vogel","year":"2021","journal-title":"Lancet"},{"key":"2026012203190594700_bib32","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1513\/AnnalsATS.202104-463OC","article-title":"Control of cardiovascular risk factors in patients with chronic obstructive pulmonary disease","volume":"19","author":"Hawkins","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203190594700_bib33","doi-asserted-by":"crossref","first-page":"e008546","DOI":"10.1161\/JAHA.118.008546","article-title":"Statin use and adverse effects among adults &gt;75 years of age: insights from the Patient and Provider Assessment of Lipid Management (PALM) Registry","volume":"7","author":"Nanna","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2026012203190594700_bib34","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/jgs.18172","article-title":"Lipid-lowering treatment among older patients with atherosclerotic cardiovascular disease","volume":"71","author":"Nanna","year":"2023","journal-title":"J Am Geriatr Soc"},{"key":"2026012203190594700_bib35","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMoa2102137","article-title":"Comparative effectiveness of aspirin dosing in cardiovascular disease","volume":"384","author":"Jones","year":"2021","journal-title":"N Engl J Med"},{"key":"2026012203190594700_bib36","doi-asserted-by":"crossref","first-page":"100256","DOI":"10.1016\/j.ajpc.2021.100256","article-title":"Aspirin for cardiovascular disease prevention among adults in the United States: trends, prevalence, and participant characteristics associated with use","volume":"8","author":"Boakye","year":"2021","journal-title":"Am J Prev Cardiol"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/21\/11\/1516\/66014346\/annalsats_21_11_1516.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/21\/11\/1516\/66014346\/annalsats_21_11_1516.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:19:31Z","timestamp":1769069971000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/21\/11\/1516\/8380694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":36,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11,1]]},"published-print":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202401-017oc","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.12.19.23300254","asserted-by":"object"}]},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,11,1]]},"assertion":[{"value":"2024-01-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}